Acknowledgement
This work was supported by the National Natural Science Foundation of China (Grant 81660089 and 81360061 to Xun Cui); the Project of Jilin Provincial Department of Education (Grant JJKH20191139KJ to Ying Zhang).
References
- Kim HY, Cho KW, Xu DY, Kang DG, Lee HS. Endogenous ACh tonically stimulates ANP secretion in rat atria. Am J Physiol Heart Circ Physiol. 2013;305:H1050-H1056. https://doi.org/10.1152/ajpheart.00469.2013
- Kiemer AK, Vollmar AM. The atrial natriuretic peptide regulates the production of inflammatory mediators in macrophages. Ann Rheum Dis. 2001;60(Suppl 3):iii68-iii70.
- De Vito P, Incerpi S, Pedersen JZ, Luly P. Atrial natriuretic peptide and oxidative stress. Peptides. 2010;31:1412-1419. https://doi.org/10.1016/j.peptides.2010.04.001
- Hong L, Xi J, Zhang Y, Tian W, Xu J, Cui X, Xu Z. Atrial natriuretic peptide prevents the mitochondrial permeability transition pore opening by inactivating glycogen synthase kinase 3β via PKG and PI3K in cardiac H9c2 cells. Eur J Pharmacol. 2012;695:13-19. https://doi.org/10.1016/j.ejphar.2012.07.053
- Lugnier C, Meyer A, Charloux A, Andres E, Geny B, Talha S. The endocrine function of the heart: physiology and involvements of natriuretic peptides and cyclic nucleotide phosphodiesterases in heart failure. J Clin Med. 2019;8:1746. https://doi.org/10.3390/jcm8101746
- Mezzasoma L, Peirce MJ, Minelli A, Bellezza I. Natriuretic peptides: the case of prostate cancer. Molecules. 2017;22:1680. https://doi.org/10.3390/molecules22101680
- Serafino A, Pierimarchi P. Atrial natriuretic peptide: a magic bullet for cancer therapy targeting Wnt signaling and cellular pH regulators. Curr Med Chem. 2014;21:2401-2409. https://doi.org/10.2174/0929867321666140205140152
- Zhang J, Zhao Z, Wang J. Natriuretic peptide receptor A as a novel target for cancer. World J Surg Oncol. 2014;12:174. https://doi.org/10.1186/1477-7819-12-174
- Foulquier S, Daskalopoulos EP, Lluri G, Hermans KCM, Deb A, Blankesteijn WM. WNT signaling in cardiac and vascular disease. Pharmacol Rev. 2018;70:68-141. https://doi.org/10.1124/pr.117.013896
- Moon RT, Kohn AD, De Ferrari GV, Kaykas A. WNT and betacatenin signalling: diseases and therapies. Nat Rev Genet. 2004;5:691-701. https://doi.org/10.1038/nrg1427
- Ng LF, Kaur P, Bunnag N, Suresh J, Sung ICH, Tan QH, Gruber J, Tolwinski NS. WNT signaling in disease. Cells. 2019;8:826. https://doi.org/10.3390/cells8080826
- Hu HH, Cao G, Wu XQ, Vaziri ND, Zhao YY. Wnt signaling pathway in aging-related tissue fibrosis and therapies. Ageing Res Rev. 2020;60:101063. https://doi.org/10.1016/j.arr.2020.101063
- Fu WB, Wang WE, Zeng CY. Wnt signaling pathways in myocardial infarction and the therapeutic effects of Wnt pathway inhibitors. Acta Pharmacol Sin. 2019;40:9-12. https://doi.org/10.1038/s41401-018-0060-4
- Stylianidis V, Hermans KCM, Blankesteijn WM. Wnt signaling in cardiac remodeling and heart failure. Handb Exp Pharmacol. 2017;243:371-393.
- Katoh M. Multi-layered prevention and treatment of chronic inflammation, organ fibrosis and cancer associated with canonical WNT/β-catenin signaling activation (Review). Int J Mol Med. 2018;42:713-725.
- Zhang CG, Jia ZQ, Li BH, Zhang H, Liu YN, Chen P, Ma KT, Zhou CY. Beta-catenin/TCF/LEF1 can directly regulate phenylephrineinduced cell hypertrophy and Anf transcription in cardiomyocytes. Biochem Biophys Res Commun. 2009;390:258-262. https://doi.org/10.1016/j.bbrc.2009.09.101
- Zhang B, Cui X, Jin HH, Hong L, Liu X, Li X, Zhang QG, Liu LP. Ginsenoside Re prevents angiotensin II-induced gap-junction remodeling by activation of PPARγ in isolated beating rat atria. Life Sci. 2017;190:36-45. https://doi.org/10.1016/j.lfs.2017.09.027
- Liu LP, Hong L, Yu L, Li HY, Ding DZ, Jin SJ, Cui X. Ouabain stimulates atrial natriuretic peptide secretion via the endothelin-1/ ET(B) receptor-mediated pathway in beating rabbit atria. Life Sci. 2012;90:793-798. https://doi.org/10.1016/j.lfs.2012.04.008
- Lim JY, Park SJ, Hwang HY, Park EJ, Nam JH, Kim J, Park SI. TGFbeta1 induces cardiac hypertrophic responses via PKC-dependent ATF-2 activation. J Mol Cell Cardiol. 2005;39:627-636. https://doi.org/10.1016/j.yjmcc.2005.06.016
- Zhang M, Hagenmueller M, Riffel JH, Kreusser MM, Bernhold E, Fan J, Katus HA, Backs J, Hardt SE. Calcium/calmodulin-dependent protein kinase II couples Wnt signaling with histone deacetylase 4 and mediates dishevelled-induced cardiomyopathy. Hypertension. 2015;65:335-344. https://doi.org/10.1161/HYPERTENSIONAHA.114.04467
- Bae IS, Kim SH. Expression and secretion of an atrial natriuretic peptide in beige-like 3T3-L1 adipocytes. Int J Mol Sci. 2019;20:6128. https://doi.org/10.3390/ijms20246128
- Liu X, Zhang Y, Hong L, Han CJ, Zhang B, Zhou S, Wu CZ, Liu LP, Cui X. Gallic acid increases atrial natriuretic peptide secretion and mechanical dynamics through activation of PKC. Life Sci. 2017;181:45-52. https://doi.org/10.1016/j.lfs.2017.05.024
- Mukhopadhyay H, Lee NY. Multifaceted roles of TAK1 signaling in cancer. Oncogene. 2020;39:1402-1413. https://doi.org/10.1038/s41388-019-1088-8
- Shibuya H, Yamaguchi K, Shirakabe K, Tonegawa A, Gotoh Y, Ueno N, Irie K, Nishida E, Matsumoto K. TAB1: an activator of the TAK1 MAPKKK in TGF-beta signal transduction. Science. 1996;24:1179-1182.
- Shintani Y, Drexler HC, Kioka H, Terracciano CM, Coppen SR, Imamura H, Akao M, Nakai J, Wheeler AP, Higo S, Nakayama H, Takashima S, Yashiro K, Suzuki K. Toll-like receptor 9 protects nonimmune cells from stress by modulating mitochondrial ATP synthesis through the inhibition of SERCA2. EMBO Rep. 2014;15:438-445. https://doi.org/10.1002/embr.201337945
- Shintani Y, Kapoor A, Kaneko M, Smolenski RT, D'Acquisto F, Coppen SR, Harada-Shoji N, Lee HJ, Thiemermann C, Takashima S, Yashiro K, Suzuki K. TLR9 mediates cellular protection by modulating energy metabolism in cardiomyocytes and neurons. Proc Natl Acad Sci U S A. 2013;110:5109-5114. https://doi.org/10.1073/pnas.1219243110
- McCarthy CG, Wenceslau CF, Ogbi S, Szasz T, Webb RC. Toll-like receptor 9-dependent AMPKα activation occurs via TAK1 and contributes to RhoA/ROCK signaling and actin polymerization in vascular smooth muscle cells. J Pharmacol Exp Ther. 2018;365:60-71. https://doi.org/10.1124/jpet.117.245746
- Grumolato L, Liu G, Haremaki T, Mungamuri SK, Mong P, Akiri G, Lopez-Bergami P, Arita A, Anouar Y, Mlodzik M, Ronai ZA, Brody J, Weinstein DC, Aaronson SA. β-Catenin-independent activation of TCF1/LEF1 in human hematopoietic tumor cells through interaction with ATF2 transcription factors. PLoS Genet. 2013;9:e1003603. https://doi.org/10.1371/journal.pgen.1003603